Stock Evaluator: Alpha Teknova, Inc. (TKNO)

Alpha Teknova, Inc. TKNO

$5.00 -0.05 -0.99%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 46,976
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Life Sciences Tools & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Commentary & Analysis


Financial Summary

Share Statistics TKNO Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $270.2 $1,774.7 31%
Shares Out (Mil) 53.6 94.8 49%
Institutional Ownership 60.5% 90.1% 39%
Float (Mil) 10.9 69.9 21%
Beta 0.47 1.20 26%
Avg Daily Volume (000s) 93 838 35%
Price Change
(52-week)
5.2% 81.0% 49%
Growth TKNO Industry
Median
Percentile
(All Stocks)
Sales (5yr) 5.3% 7.8% 37%
Net Income (5yr) (46.7%) (13.7%) 8%
EPS (5yr) (32.1%) 0.7% 7
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 16.8% (15.0%) 76%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials TKNO Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $42 $763 18%
Net Income (TTM) (Mil) ($17) ($14) 25%
EPS (TTM) ($0.321) ($0.200) 31%
Operating Cash Flow (TTM) (Mil) ($8) $53 21%
Net Cash Flow (TTM) (Mil) $1 ($5) 47%
Long-Term Debt (Q1) (Mil) $26 $270 34%
Enterprise Value (Q1) (Mil) $215 $2,430 27%
Valuation TKNO Industry
Median
Percentile
(All Stocks)
P/B 4.17 3.00 74%
P/E na 43.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 5.3 na
Ratios TKNO Industry
Median
Percentile
(All Stocks)
Gross Margin 34.0% 47.6% 41%
Net Margin (41.1%) (2.9%) 13%
ROA (16.1%) (3.2%) 22%
ROE (23.9%) (4.5%) 22%
Liabilities to Assets 34.2% 43.0% 25%
F-Score 5 5 51%

Alpha Teknova, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors